This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Yan Zhang: Innovator in Antibody Treatment
Introduction
Yan Zhang is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medical treatments, particularly in the development of antibody therapies. His innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Yan Zhang holds a patent for the invention titled "IP-10 antibody dosage escalation regimens." This patent outlines a method for treating diseases related to Interferon gamma inducible protein 10 (IP-10). The method involves administering a predetermined dosage of an anti-IP-10 antibody, monitoring its levels in the subject, and adjusting the dosage as necessary to effectively treat the disease. This innovative approach has the potential to improve treatment outcomes for patients suffering from IP-10-related conditions.
Career Highlights
Yan Zhang is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His work at the company focuses on advancing therapeutic solutions that can significantly impact patient care. With a strong background in research and development, he has been instrumental in driving forward innovative treatments.
Collaborations
Yan collaborates with talented professionals in his field, including Allison Y Luo and Wendy L Trigona. These collaborations enhance the research and development process, fostering an environment of innovation and discovery.
Conclusion
In summary, Yan Zhang is a pioneering inventor whose work in antibody treatments is making a difference in the medical field. His patent on IP-10 antibody dosage escalation regimens exemplifies his commitment to improving patient outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
